English

DERMA SCIENCES, INC.

EDGAR

DSCI Filing amendment (SC 13D/A) · filed 2017-02-28

128 filing records in this dataset, filed from 1996-08-13 to 2017-02-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

15.8 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 15845934 USD Source

Operating margin

-3.74%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -592470 USD Source
Revenue: 15845934 USD Source

Operating cash flow

-668 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 457603 USD Source
Operating Cash Flow: 1125302 USD Source

Free cash flow

-912 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 457603 USD Source
Operating Cash Flow: 1125302 USD Source
Capital Expenditure: 931954 USD Source
Capital Expenditure: 687238 USD Source

Cash and cash equivalents: 26 million USD 2016-09-30 Source
Exact value

25974166 USD
Long-term debt including current maturities: Not available
Shares outstanding: 28.3 million shares 2016-09-30 Source
Exact value

28269225 shares

Reported share-count change

9.54% · 2.46 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

25806549 shares · 2015-09-30· Source
28269225 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

61.4 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 56474056 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 41170621 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 14371271 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 15879609 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 15845934 USD · 2011-07-01 – 2011-09-30 Source

Net income

-10.4 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Net income: -9249000 USD · 2015-10-01 – 2015-12-31 Source
Net income: -1757753 USD · 2016-01-01 – 2016-03-31 Source
Net income: 1982536 USD · 2016-04-01 – 2016-06-30 Source
Net income: -1391571 USD · 2016-07-01 – 2016-09-30 Source

Operating cash flow

-12.7 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -35422582 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -27309403 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -3741419 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -4388747 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -3741419 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -4585381 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -4388747 USD · 2016-01-01 – 2016-06-30 Source

Capital expenditure

908 thousand USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Capital expenditure: 1811325 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 1138895 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 107750 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 165093 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 107750 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 235128 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 165093 USD · 2016-01-01 – 2016-06-30 Source

Free cash flow

-13.6 million USD

2015-10-01 – 2016-09-30

Exact inputs and evidence

Operating cash flow: -35422582 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -27309403 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -3741419 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -4388747 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -3741419 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -4585381 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -4388747 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 1811325 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 1138895 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 107750 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 165093 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 107750 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 235128 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 165093 USD · 2016-01-01 – 2016-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-02-28.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2010-12-31
Operating income: 10 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 11 of 11 periods available· newest 2015-12-31
Capital expenditure: 6 of 11 periods available· newest 2015-12-31
Total assets: 11 of 11 periods available· newest 2015-12-31
Total liabilities: 11 of 11 periods available· newest 2015-12-31
Current assets: 11 of 11 periods available· newest 2015-12-31
Current liabilities: 11 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 1.66 million

Prior period

−USD 39.77 million

2014-01-01 – 2014-12-31
Current period

−USD 38.11 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-38107480 − -39771555 = 1664075 USD

-39771555 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-38107480 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Year-over-year change in Net income: 1664075 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -38107480 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#710260 Filing: 000114420416088236 Input fundies:NetIncome: -39771555 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#710401 Filing: 000114420416088236
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 9.42 million

Prior period

−USD 26.01 million

2014-01-01 – 2014-12-31
Current period

−USD 35.42 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-35422582 − -26007138 = -9415444 USD

-26007138 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-35422582 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Year-over-year change in Operating cash flow: -9415444 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -35422582 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169728 Filing: 000114420416088236 Input fundies:OperatingCashFlow: -26007138 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169965 Filing: 000114420416088236
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+4.5%

Prior period

USD 1.73 million

2014-01-01 – 2014-12-31
Current period

USD 1.81 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

1811325 − 1732523 = 78802 USD

1732523 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
1811325 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Year-over-year change in Capital expenditure: 78802 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1811325 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170538 Filing: 000114420416088236 Input fundies:CapitalExpenditure: 1732523 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170733 Filing: 000114420416088236
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 56.47 million 100% of revenue
Operating costs Derived USD 58.14 million 103% of revenue
Operating income −USD 1.67 million −3% of revenue
Tax, interest and other Derived USD 778,439 1.4% of revenue
Net income −USD 2.45 million −4.3% of revenue

Cash

Operating cash flow −USD 291,207 −0.5% of revenue
Capital expenditure USD 634,939 1.1% of revenue
Free cash flow Derived −USD 926,146 −1.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 96%
2007 Operating loss: operating costs were 104% of revenue.
2008 Operating loss: operating costs were 106% of revenue.
2009 Operating loss: operating costs were 101% of revenue.
2010 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	27887391	26774230 Derived	1113161	444422 Derived	668739	Unavailable	Source 2006-01-01 – 2006-12-31: 27887391 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 1113161 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 668739 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 1999179 USD Inspect Operating Cash Flow Open source
2007 2007-01-01 – 2007-12-31	34135401	35409423 Derived	-1274022	1010583 Derived	-2284605	Unavailable	Source 2007-01-01 – 2007-12-31: 34135401 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -1274022 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -2284605 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 1368117 USD Inspect Operating Cash Flow Open source
2008 2008-01-01 – 2008-12-31	50199428	53139873 Derived	-2940445	1021492 Derived	-3961937	Unavailable	Source 2008-01-01 – 2008-12-31: 50199428 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -2940445 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -3961937 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -4743967 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	48526158	49003231 Derived	-477073	805652 Derived	-1282725	Unavailable	Source 2009-01-01 – 2009-12-31: 48526158 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -477073 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -1282725 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 2654204 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	56474056	58144481 Derived	-1670425	778439 Derived	-2448864	-926146 Derived	Source 2010-01-01 – 2010-12-31: 56474056 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -1670425 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2448864 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -291207 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 634939 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 56.5M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	22799640	Revenue: 22799640 Open source
20062006-12-31	Revenue	27887391	Revenue: 27887391 Open source
20072007-12-31	Revenue	34135401	Revenue: 34135401 Open source
20082008-12-31	Revenue	50199428	Revenue: 50199428 Open source
20092009-12-31	Revenue	48526158	Revenue: 48526158 Open source
20102010-12-31	Revenue	56474056	Revenue: 56474056 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

16.4% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 22799640 Open source
20062006-12-31	Year over year	22.3%	Revenue: 27887391 Open source Revenue: 22799640 Open source
20072007-12-31	Year over year	22.4%	Revenue: 34135401 Open source Revenue: 27887391 Open source
20082008-12-31	Year over year	47.1%	Revenue: 50199428 Open source Revenue: 34135401 Open source
20092009-12-31	Year over year	-3.3%	Revenue: 48526158 Open source Revenue: 50199428 Open source
20102010-12-31	Year over year	16.4%	Revenue: 56474056 Open source Revenue: 48526158 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3% 2010

Net margin -4.3% 2010

Free cash flow margin -1.6% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-12-31	Operating margin	Not reported	Revenue: 22799640 Open source
20062006-12-31	Operating margin	4%	Operating Income: 1113161 Open source Revenue: 27887391 Open source
20072007-12-31	Operating margin	-3.7%	Operating Income: -1274022 Open source Revenue: 34135401 Open source
20082008-12-31	Operating margin	-5.9%	Operating Income: -2940445 Open source Revenue: 50199428 Open source
20092009-12-31	Operating margin	-1%	Operating Income: -477073 Open source Revenue: 48526158 Open source
20102010-12-31	Operating margin	-3%	Operating Income: -1670425 Open source Revenue: 56474056 Open source
20052005-12-31	Net margin	-4.8%	Net Income: -1099990 Open source Revenue: 22799640 Open source
20062006-12-31	Net margin	2.4%	Net Income: 668739 Open source Revenue: 27887391 Open source
20072007-12-31	Net margin	-6.7%	Net Income: -2284605 Open source Revenue: 34135401 Open source
20082008-12-31	Net margin	-7.9%	Net Income: -3961937 Open source Revenue: 50199428 Open source
20092009-12-31	Net margin	-2.6%	Net Income: -1282725 Open source Revenue: 48526158 Open source
20102010-12-31	Net margin	-4.3%	Net Income: -2448864 Open source Revenue: 56474056 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 22799640 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 27887391 Open source Operating Cash Flow: 1999179 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 34135401 Open source Operating Cash Flow: 1368117 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 50199428 Open source Operating Cash Flow: -4743967 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 48526158 Open source Operating Cash Flow: 2654204 Open source
20102010-12-31	Free cash flow margin	-1.6%	Revenue: 56474056 Open source Operating Cash Flow: -291207 Open source Capital Expenditure: 634939 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -291.2K 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	1999179	Operating Cash Flow: 1999179 Open source
20072007-12-31	Operating cash flow	1368117	Operating Cash Flow: 1368117 Open source
20082008-12-31	Operating cash flow	-4743967	Operating Cash Flow: -4743967 Open source
20092009-12-31	Operating cash flow	2654204	Operating Cash Flow: 2654204 Open source
20102010-12-31	Operating cash flow	-291207	Operating Cash Flow: -291207 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -926.1K 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	Unavailable	No source recorded
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: 1999179 Open source
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: 1368117 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4743967 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: 2654204 Open source
20102010-12-31	Free cash flow	-926146	Operating Cash Flow: -291207 Open source Capital Expenditure: 634939 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

27.8% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Liabilities / assets	33.5%	Total Liabilities: 3449386 Open source Total Assets: 10298186 Open source
20062006-12-31	Liabilities / assets	19.1%	Total Liabilities: 3527909 Open source Total Assets: 18505921 Open source
20072007-12-31	Liabilities / assets	44.1%	Total Liabilities: 15815886 Open source Total Assets: 35870841 Open source
20082008-12-31	Liabilities / assets	40.9%	Total Liabilities: 14814824 Open source Total Assets: 36207322 Open source
20092009-12-31	Liabilities / assets	36.2%	Total Liabilities: 12068775 Open source Total Assets: 33299875 Open source
20102010-12-31	Liabilities / assets	27.8%	Total Liabilities: 10289150 Open source Total Assets: 36969863 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.1× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	2.06×	Current Assets: 6112860 Open source Current Liabilities: 2960931 Open source
20062006-12-31	Current assets / current liabilities	3.1×	Current Assets: 8514466 Open source Current Liabilities: 2746417 Open source
20072007-12-31	Current assets / current liabilities	1.54×	Current Assets: 15390327 Open source Current Liabilities: 10021289 Open source
20082008-12-31	Current assets / current liabilities	1.65×	Current Assets: 17103720 Open source Current Liabilities: 10364069 Open source
20092009-12-31	Current assets / current liabilities	1.77×	Current Assets: 15562635 Open source Current Liabilities: 8771054 Open source
20102010-12-31	Current assets / current liabilities	2.1×	Current Assets: 18953410 Open source Current Liabilities: 9009481 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	USD 668,739 Exact value Exact value: 668739 USD 2006-01-01 – 2006-12-31: 668739 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2006-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: 668739 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 668739 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001088020-08-000017.txt#3972 The citation records this snapshot. The page link may show a newer release later.	USD 2 million Exact value Exact value: 1999179 USD 2006-01-01 – 2006-12-31: 1999179 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2006-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: 1999179 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1999179 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001088020-08-000017.txt#4109 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 2.28 million Exact value Exact value: -2284605 USD 2007-01-01 – 2007-12-31: -2284605 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2007-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -2284605 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2284605 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001088020-09-000054.txt#3658 The citation records this snapshot. The page link may show a newer release later.	USD 1.37 million Exact value Exact value: 1368117 USD 2007-01-01 – 2007-12-31: 1368117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2007-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: 1368117 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1368117 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001088020-09-000054.txt#3780 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 3.96 million Exact value Exact value: -3961937 USD 2008-01-01 – 2008-12-31: -3961937 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2008-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -3961937 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3961937 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001144204-10-017302.txt#6095 The citation records this snapshot. The page link may show a newer release later.	−USD 4.74 million Exact value Exact value: -4743967 USD 2008-01-01 – 2008-12-31: -4743967 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2008-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -4743967 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4743967 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001144204-10-017302.txt#6389 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 1.28 million Exact value Exact value: -1282725 USD 2009-01-01 – 2009-12-31: -1282725 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2009-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -1282725 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1282725 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001144204-11-018050.txt#5261 The citation records this snapshot. The page link may show a newer release later.	USD 2.65 million Exact value Exact value: 2654204 USD 2009-01-01 – 2009-12-31: 2654204 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2009-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: 2654204 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2654204 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/0001144204-11-018050.txt#5525 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 2.45 million Exact value Exact value: -2448864 USD 2010-01-01 – 2010-12-31: -2448864 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2010-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -2448864 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2448864 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420412017767/dsci-20111231.xml#21944 Filing: 000114420412017767 The citation records this snapshot. The page link may show a newer release later.	−USD 291,207 Exact value Exact value: -291207 USD 2010-01-01 – 2010-12-31: -291207 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2010-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -291207 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -291207 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420412017767/dsci-20111231.xml#19976 Filing: 000114420412017767 The citation records this snapshot. The page link may show a newer release later.	USD 634,939 Exact value Exact value: 634939 USD 2010-01-01 – 2010-12-31: 634939 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2010-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 634939 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 634939 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420412017767/dsci-20111231.xml#23205 Filing: 000114420412017767 The citation records this snapshot. The page link may show a newer release later.	−USD 926,146 Calculation and evidence -291207 − 634939 USD Exact free cash flow: -926146 USD 2010-01-01 – 2010-12-31: -291207 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 634939 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2010-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -926146 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -291207 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420412017767/dsci-20111231.xml#19976 Filing: 000114420412017767 Input fundies:CapitalExpenditure: 634939 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420412017767/dsci-20111231.xml#23205 Filing: 000114420412017767 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 4.34 million Exact value Exact value: -4340411 USD 2011-01-01 – 2011-12-31: -4340411 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2011-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -4340411 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4340411 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420413018386/dsci-20121231.xml#431225 Filing: 000114420413018386 The citation records this snapshot. The page link may show a newer release later.	USD 249,542 Exact value Exact value: 249542 USD 2011-01-01 – 2011-12-31: 249542 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2011-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: 249542 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 249542 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420413018386/dsci-20121231.xml#430773 Filing: 000114420413018386 The citation records this snapshot. The page link may show a newer release later.	USD 978,949 Exact value Exact value: 978949 USD 2011-01-01 – 2011-12-31: 978949 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2011-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 978949 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 978949 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420413018386/dsci-20121231.xml#452255 Filing: 000114420413018386 The citation records this snapshot. The page link may show a newer release later.	−USD 729,407 Calculation and evidence 249542 − 978949 USD Exact free cash flow: -729407 USD 2011-01-01 – 2011-12-31: 249542 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 978949 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2011-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -729407 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 249542 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420413018386/dsci-20121231.xml#430773 Filing: 000114420413018386 Input fundies:CapitalExpenditure: 978949 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420413018386/dsci-20121231.xml#452255 Filing: 000114420413018386 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 12.07 million Exact value Exact value: -12070431 USD 2012-01-01 – 2012-12-31: -12070431 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2012-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -12070431 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12070431 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420415015419/dsci-20141231.xml#467433 Filing: 000114420415015419 The citation records this snapshot. The page link may show a newer release later.	−USD 11.9 million Exact value Exact value: -11904273 USD 2012-01-01 – 2012-12-31: -11904273 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2012-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -11904273 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11904273 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420415015419/dsci-20141231.xml#168153 Filing: 000114420415015419 The citation records this snapshot. The page link may show a newer release later.	USD 826,208 Exact value Exact value: 826208 USD 2012-01-01 – 2012-12-31: 826208 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2012-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 826208 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 826208 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420415015419/dsci-20141231.xml#852687 Filing: 000114420415015419 The citation records this snapshot. The page link may show a newer release later.	−USD 12.73 million Calculation and evidence -11904273 − 826208 USD Exact free cash flow: -12730481 USD 2012-01-01 – 2012-12-31: -11904273 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 826208 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2012-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -12730481 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11904273 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420415015419/dsci-20141231.xml#168153 Filing: 000114420415015419 Input fundies:CapitalExpenditure: 826208 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420415015419/dsci-20141231.xml#852687 Filing: 000114420415015419 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 23.96 million Exact value Exact value: -23964053 USD 2013-01-01 – 2013-12-31: -23964053 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2013-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -23964053 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23964053 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#175469 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 17.2 million Exact value Exact value: -17202157 USD 2013-01-01 – 2013-12-31: -17202157 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2013-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -17202157 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17202157 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#177829 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	USD 695,776 Exact value Exact value: 695776 USD 2013-01-01 – 2013-12-31: 695776 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2013-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 695776 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 695776 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#178236 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 17.9 million Calculation and evidence -17202157 − 695776 USD Exact free cash flow: -17897933 USD 2013-01-01 – 2013-12-31: -17202157 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 695776 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2013-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -17897933 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17202157 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#177829 Filing: 000114420416088236 Input fundies:CapitalExpenditure: 695776 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#178236 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 39.77 million Exact value Exact value: -39771555 USD 2014-01-01 – 2014-12-31: -39771555 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2014-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -39771555 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39771555 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#710401 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 26.01 million Exact value Exact value: -26007138 USD 2014-01-01 – 2014-12-31: -26007138 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2014-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -26007138 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26007138 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169965 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	USD 1.73 million Exact value Exact value: 1732523 USD 2014-01-01 – 2014-12-31: 1732523 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2014-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 1732523 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1732523 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170733 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 27.74 million Calculation and evidence -26007138 − 1732523 USD Exact free cash flow: -27739661 USD 2014-01-01 – 2014-12-31: -26007138 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 1732523 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2014-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -27739661 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26007138 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169965 Filing: 000114420416088236 Input fundies:CapitalExpenditure: 1732523 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170733 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 38.11 million Exact value Exact value: -38107480 USD 2015-01-01 – 2015-12-31: -38107480 USD Inspect Net Income Open source Share or cite Citation for Net Income · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Net Income: -38107480 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38107480 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#710260 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 35.42 million Exact value Exact value: -35422582 USD 2015-01-01 – 2015-12-31: -35422582 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Operating Cash Flow: -35422582 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35422582 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169728 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	USD 1.81 million Exact value Exact value: 1811325 USD 2015-01-01 – 2015-12-31: 1811325 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Capital Expenditure: 1811325 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1811325 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170538 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.	−USD 37.23 million Calculation and evidence -35422582 − 1811325 USD Exact free cash flow: -37233907 USD 2015-01-01 – 2015-12-31: -35422582 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1811325 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DERMA SCIENCES, INC. · 2015-12-31 DERMA SCIENCES, INC. (edgar:892160) Free cash flow: -37233907 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:20:49Z Snapshot: 50b9eaad4e70810db99fb0d2d0bb167ba6f80782a583e7cfcd7019bef0e9bdbe Dimensions: Consolidated View: https://fundies.io/companies/edgar/892160?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35422582 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#169728 Filing: 000114420416088236 Input fundies:CapitalExpenditure: 1811325 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892160/000114420416088236/dsci-20151231.xml#170538 Filing: 000114420416088236 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

128 filings · 1,716 latest values · 1,716 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000892160, 892160, DSCI, edgar:892160

Also known as DERMA SCIENCES INC, DERMA SCIENCES, INC.

DERMA SCIENCES, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation